PR Newswire (press release) Kalorama Information's report, The Worldwide Market for In Vitro Diagnostic Tests, 9 th Edition provides detailed profiles of Siemens and other significant IVD companies. The report can be obtained at ... 更多 »
Nasdaq ERBA Diagnostics, Inc. (NYSE MKT:ERB) is a fully integrated in vitro diagnostics company, offering a comprehensive suite of clinical testing products throughout the U.S. and emerging markets.
Laboratory Network As a result of improved knowledge and understanding of the human genome, quantitative real-time PCR (qPCR) has become an increasingly important tool for in vitro diagnostics and patient ... Integrated DNA Technologies receives licence for MGB Eclipse Probes Zenopa 此专题所有 2 篇报道 »
Business Wire (press release) In the report, the IVD market has been segmented on the basis of techniques, products, applications, and end-users. The market assessment of the above mentioned segments is made across the ... 更多 »
MarketWatch SOUTH SAN FRANCISCO, Calif., Nov 17, 2014 (BUSINESS WIRE) -- Sequenta, Inc., a biotechnology company developing clinical diagnostics based on immune cell receptor genes, today announced ... 更多 »
Zawya (registration) Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Roche's personalised healthcare strategy aims at providing ... Accurate diagnosis a prerequisite for effective treatment gulfnews.com 此专题所有 3 篇报道 »
Business Wire (press release) The IVD market revenue is expected to reach $74.65 billion by 2020, from the market value of $53.32 billion in 2013, at a CAGR of 5.34% during 2014-2020. Geographically, Asia Pacific is the fastest ... 更多 »
CNNMoney As the first FDA-cleared, protein-based In Vitro Diagnostic Multivariate Index Assay, OVA1 represents a new class of software-based diagnostics. For additional information, including published clinical ... 更多 »
